Considering the adverse health effects of smoking, the American Diabetes Association recommends smoking cessation among diabetic patients (1). One-year follow-up data on smoking cessation among diabetic patients are not available (2). We conducted this study to find the effectiveness of diabetes-specific smoking cessation counseling by a nondoctor health professional (NDHP) in addition to quitting advice by a doctor at 1 year. We recruited 224 adult male diabetic patients aged ≥18 years who smoked in the previous month from two diabetes clinics of Kerala for our randomized controlled trial. They were randomized into two equal groups: intervention-1 and intervention-2. Patients in both groups were asked and advised by a doctor to quit smoking and education materials on smoking-related complications were provided. The intervention-2 group received four additional diabetes-specific 30-min smoking cessation counseling sessions at baseline and 1, 3, and 6 months using the five “As” (Ask, Assess, Advise, Assist, Arrange) and the five “Rs” (Relevance, Risks, Rewards, Roadblocks, Repetition) from a trained and certified NDHP. The NDHP at each clinic was instructed to document the details of cessation counseling offered to a sample of 15 patients using the five As and five Rs. One of the authors (M.N.) conducted an examination based on these 15 brief interventions to assess their cessation skills. University of Arizona issued a certificate for the counselor titled “Basic Tobacco Cessation Competency” on successful performance in the examination. The intervention was stopped at 6 months and the results were published (3).
We followed up 86.6% of patients either in the hospital or at their homes directly or through phone calls at 1 year (Fig. 1) and assessed the quit rate (abstinence of smoking for at least 7 days is reported to highly correlate with prolonged abstinence [4]) and harm reduction (reduction of smoking more than 50% of baseline use). Salivary cotinine tests after 1-year follow-up confirmed self-reported cessation in 86% (5). Odds of quitting in intervention-2 group, adjusted for age, education, occupation, presence of any other chronic disease, duration of diabetes, and number of cigarettes/bidis smoked per day at baseline, were significantly higher compared with intervention-1 group (adjusted odds ratio [AOR] 3.35; 95% CI 1.82–6.18). Similarly, the odds of quitting or harm reduction in the intervention-2 group were higher compared with the intervention-1 group (AOR 2.21; 95% CI 1.24–3.93). Our NDHP with a university degree was a regular employee of the clinic. NDHPs, including nurses and other grassroot-level health professionals employed by the various Indian state governments, can be adequately trained in brief intervention as part of the ongoing national program for prevention and control of cancer, diabetes, cardiovascular disease, and stroke and can provide smoking cessation counseling similar to our NDHP. Similarly, using the funds from this national program, doctors in both the public and private sector attached to diabetes clinics can be given orientation to the need for smoking cessation among smokers attending these clinics. This team approach for smoking cessation is likely to result in a reduction of diabetes complications due to smoking.
Figure 1.
Patient flow diagram.
Article Information
Funding. The Quit Tobacco International project was supported by a grant from the Fogarty International Center of the U.S. National Institutes of Health (R01-TW-005969-01).
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
Author Contributions. K.R.T. contributed to the conception, design, and revision of the manuscript with critical contribution for intellectual content and gave final approval of the version to be published. G.K.M. and M.N. contributed to the conception, design, and revision of the manuscript for intellectual content and analysis and interpretation of data. M.H. and G.V. contributed to the conception, design, and revision of the manuscript with critical contribution for intellectual content. P.S.S. contributed to the analysis and interpretation of data and to the critical revision of the manuscript. K.R.T. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Prior Presentation. Parts of this study were presented in abstract form at the 73rd Scientific Sessions of the American Diabetes Association, Chicago, IL, 21–25 June 2013.
Footnotes
Clinical trial reg. no. CTRI/2012/01/002327, www.ctri.nic.in.
References
- 1.American Diabetes Association Standards of medical care in diabetes—2013. Diabetes Care 2013;36(Suppl. 1):S11–S66 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomized controlled trials. BMJ Open 2014;6:4:e004107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thankappan KR, Mini GK, Daivadanam M, Vijayakumar G, Sarma PS, Nichter M. Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India. BMC Public Health 2013;13:47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hughes JR, Carpenter MJ, Naud S. Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review. Nicotine Tob Res 2010;12:756–762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mini GK, Nichter M, Radhakrishnan RN, Thankappan KR. Confirmation of self-reported non-smoking status by salivary cotinine among diabetes patients in South India [article online], 2014. Clin Epidemiol Glob Health; Available from http://dx.doi.org/10.1016/j.cegh.2014.05.003. Accessed 6 October 2014 [Google Scholar]